Predict the Attack: How to Forecast Paragraph IV Drug Patent Challenge Filings and Neutralize Skinny Label Threats
In the high-stakes world of pharmaceutical innovation, timing isn’t just everything—it’s the difference between market dominance and missed opportunities. Yet, many companies find themselves caught off guard by the unpredictable wave of Paragraph IV pa…